Gland Pharma Limited: mutual fund holdings, buys & sells (Sept 2026)

Schemes holding Gland Pharma Limited^{(Nov 2020 – Sept 2026)}

Schemes holding Gland Pharma Limited in Sept 2026. Tick up to 2 to plot them.
Plot	145 schemes ·	₹ Cr
	HDFC Mid Cap Fund	1,759
	Kotak Mid Cap Fund	1,063
	SBI Large and Midcap Fund	924
	Nippon India Growth Mid Cap Fund	812
	Nippon India Small Cap Fund	531
	Mirae Asset Large Midcap Fund	491
	HDFC Large Mid Cap Fund	406
	DSP Small Cap Fund	382
	Axis Small Cap Fund	373
	ICICI Prudential India Opportunities Fund	366
	Nippon India Multi Cap Fund	346
	Canara Robeco Small Cap Fund	324
	SBI Contra Fund	323
	Mirae Asset Midcap Fund	301
	Nippon India ELSS Tax Saver Fund	290
	Axis Midcap Fund	261
	Nippon India Pharma Fund	232
	DSP Healthcare Fund	231
	Sundaram Mid Cap Fund	231
	Mirae Asset Large Cap Fund	185
	SBI Healthcare Opportunities Fund	174
	Axis Large Mid Cap Fund	155
	HDFC Multi Cap Fund	150
	HDFC Manufacturing Fund	148
	Axis ELSS Tax Saver Fund	145
	Axis Multicap Fund	135
	ICICI Prudential Healthcare Fund	135
	Mirae Asset Small Cap Fund	107
	Mirae Asset Multicap Fund	107
	HSBC Large Mid Cap Fund	105
	Canara Robeco Aggressive Hybrid Fund	105
	Aditya Birla Sun Life MNC Fund	103
	Mirae Asset Healthcare Fund	93.9
	Aditya Birla Sun Life Small Cap Fund	90.1
	SBI Conservative Hybrid Fund	89.3
	DSP Mid Cap Fund	81.8
	Mirae Asset ELSS Tax Saver Fund	75
	ICICI Prudential Manufacturing Fund	69.3
	WhiteOak Capital Mid Cap Fund	67
	Axis India Manufacturing Fund	66.8
	TRUSTMF Small Cap Fund	65.1
	DSP Multi Cap Fund	64.8
	Aditya Birla Sun Life Aggressive Hybrid Fund	63.8
	Sundaram Aggressive Hybrid Fund	63.6
	HDFC Pharma and Healthcare Fund	62.3
	HDFC Retirement Fund Equity Plan	50.7
	Sundaram Multi Cap Fund	49.9
	Aditya Birla Sun Life Value Fund	49.2
	HSBC Multi Asset Allocation Fund	42.1
	Aditya Birla Sun Life Large Mid Cap Fund	41.4

HDFC Mid Cap Fund
Kotak Mid Cap Fund

Market value of Gland Pharma Limited in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	HDFC Mid Cap Fund	Kotak Mid Cap Fund
Sept 2025	₹1,167 Cr	₹0 Cr
Oct 2025	₹1,130 Cr	₹0 Cr
Nov 2025	₹1,031 Cr	₹0 Cr
Dec 2025	₹1,009 Cr	₹0 Cr
Jan 2026	₹1,129 Cr	₹0 Cr
Feb 2026	₹1,151 Cr	₹0 Cr
Mar 2026	₹1,072 Cr	₹0 Cr
Apr 2026	₹1,106 Cr	₹0 Cr
May 2026	₹1,422 Cr	₹0 Cr
Jun 2026	₹1,576 Cr	₹0 Cr
Jul 2026	₹1,519 Cr	₹0 Cr
Aug 2026	₹1,751 Cr	₹0 Cr
Sept 2026	₹1,759 Cr	₹1,063 Cr

Fig. 1.Market value of Gland Pharma Limited in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Fund houses

		% of total
HDFC	15	19.94

Nippon	10	17.35

SBI	7	11.38

Mirae	13	10.38

Axis	13	8.93

Kotak	6	8.22

DSP	9	5.65

ICICI	12	5.03

Canara Robeco	5	3.79

Sundaram	7	3.06

Other fund houses	48	6.28

Scheme types

Schemes

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Schemes buying and selling Gland Pharma Limited^{(Oct 2025 – Sept 2026)}

Schemes buying and selling Gland Pharma Limited. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.